Seeing Is Believing
Currently out of the existing stock ratings of Roger Song, 27 are a BUY (75%), 8 are a HOLD (22.22%), 1 are a SELL (2.78%).
Analyst Roger Song, currently employed at JEFFERIES, carries an average stock price target met ratio of 26.43% that have a potential upside of 18.88% achieved within 77 days.
Roger Song’s has documented 72 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on REPL, Replimune Group at 04-Dec-2024.
Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 11/10/2023. The price target of $4.8 was fulfilled within 6 days with a profit of $0.61 (14.56%) receiving and performance score of 24.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1
$0.7 (233.33%)
$4
1 years 4 months 6 days ago
(14-Aug-2023)
0/6 (0%)
$0.49 (96.08%)
Hold
$1
$0.7 (233.33%)
$4
1 years 4 months 9 days ago
(11-Aug-2023)
0/6 (0%)
$0.44 (78.57%)
Buy
$25
1 years 4 months 10 days ago
(11-Aug-2023)
0/4 (0%)
$18.48 (1258.95%)
Buy
$20
1 years 8 months 19 days ago
(31-Mar-2023)
1/3 (33.33%)
$14.51 (264.30%)
220
Buy
$27
2 years 7 months 1 days ago
(19-May-2022)
0/1 (0%)
$18.23 (207.87%)
Which stock is Roger Song is most bullish on?
Which stock is Roger Song is most reserved on?
What Year was the first public recommendation made by Roger Song?